FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis
| 17302XAK2 | 99.98 0.15 0.15% |
About 61% of CITGO's investor base is looking to short. The analysis of the overall prospects from investing in CITGO Petroleum 7 suggests that many traders are, at the present time, alarmed. The current market sentiment, together with CITGO's historical and current headlines, can help investors time the market. In addition, many technical investors use CITGO Petroleum 7 bond news signals to limit their universe of possible portfolio assets.
CITGO |
Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that the U.S. Food and Drug Administration has granted Fast Track Designation to LPCN 1148 as a treatment for sarcopenia in patients with decompensated cirrhosis. LPCN 1148, an oral prodrug of bioidentical testosterone, was recently studied in a proof-of-concept Phase 2 study in patients with decompensated
Read at finance.yahoo.com
 |
CITGO Fundamental Analysis
We analyze CITGO's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CITGO using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CITGO based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
CITGO Petroleum cannot be rated in Probability Of Bankruptcy category at this point.Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
CITGO Petroleum 7 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CITGO bond to make a market-neutral strategy. Peer analysis of CITGO could also be used in its relative valuation, which is a method of valuing CITGO by comparing valuation metrics with similar companies.
Peers
CITGO Related Equities
Other Information on Investing in CITGO Bond
CITGO financial ratios help investors to determine whether CITGO Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CITGO with respect to the benefits of owning CITGO security.